4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-034336
Chief Medical Officer sold 1,185 shares at an average $2.91 ($3,452)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2022-10-25 | Sale | −541 | $2.81 | $1,520 | 265,937 | D |
| Karlin Dan Chief Medical Officer | 2022-10-27 | Sale | −644 | $3.00 | $1,932 | 265,293 | D |
| Open-market sales · 1,185 sh · avg $2.91 · $3,452 | |||||||
Loading xslF345X03/doc4.xml…